Skip to main content

Table 3 Implementation of the TB related WHO packages of care for AHD patients before and after the introduction of WHO guideline for the management of Advanced HIV Disease, N = 1315

From: Implementation of WHO guidelines on management of advanced HIV disease and its impact among TB co-infected patients in Tanzania: a retrospective follow-up study

TB service provided Overall (July 2013-Sept 2018) Before guideline for management of AHD (Jan 2013- June 2017) n (%) During guideline for management of AHD (July 2017-sept 2018) n (%) P-value
TB diagnosis
 TB patient 102 (4.8) 45 (7.8) 57 (8.1) 0.852
 Not TB patient 1178 (88.9) 531 (92.2) 647 (91.9)
Total 1280 576 704  
IPT at enrolment
 Received IPT 5 (0.6) 4 (0.9) 1 (0.2) 0.155*
 No IPT 893 (67.9) 421 (99.1) 472 (99.8)
 Total 898 587 1253  
Sputum Xpert as the first test for TB diagnosis
 Tested 57 (4.4) 21 (3.7) 36 (5.0) 0.146
 Not tested 1233 (95.6) 553 (96.3) 680 (95.0)  
 Total 1290 574 716  
Tailored counselling^
 Counselled 16 (12.1) 7 (10.4) 9 (13.9) 0.37
 Not Counselled 116 (87.9) 60 (89.6) 56 (86.2)  
Urine LF-LAM test
 Tested 0 0 (0) 0 (0)  
 Not Tested 1275 564 (100) 711 (100)  
ART initiation (TB patients)
 Less than 2 weeks 85 (60.3) 35 (62.5) 50 (58.8)  < 0.398
 More than 2 weeks 56 (39.7) 21 (37.5) 35 (41.2)  
ART initiation (non-TB patients)
 Less than 2 weeks 932 (86.3) 381 (77.0) 551 (94.2)  < 0.001
 More than 2 weeks 148 (13.7) 114 (23.0) 34 (5.8)
  1. *Fisher’s exact test was used to calculate p-value
  2. ^ Tailored counselling is given to HIV patients who fail to attain viral load suppression at a specified time (in this case 6-month from ART start)